IL-17A treatment section added to Psoriasis Knowledge Centre
A new educational area focused on treatments for psoriasis has been added to Medthority.com. Located within the Psoriasis Knowledge Centre, IL-17A in Psoriasis has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A.
Content is arranged within multiple sections that are easy to navigate. Users can find expert videos, clinical slide decks on topics such as disease perception and emerging therapies, congress highlights from the latest symposia, key publications and links to useful resources.
This free resource is intended for healthcare professionals involved in the treatment and management of patients with psoriasis.
This resource has been developed in collaboration with Novartis Pharma AG.